INTS
Intensity Therapeutics, Inc. (INTS) ESG Analysis Analysis (2026)
No material changes this month.
Environmental
INTS shows limited disclosed environmental intensity data, which reduces transparency versus larger peers that typically report emissions, energy, and water metrics more comprehensively.
Near-zero reported R&D-to-revenue does not indicate environmental leadership, leaving the company behind peers that use product innovation to lower lifecycle impacts.
The very low debt-to-equity ratio suggests less balance-sheet pressure to fund environmental remediation, but peers with stronger disclosure still provide clearer ESG accountability.
Absent evidence of material environmental programs or targets, INTS appears broadly average to weaker than peers on environmental management and reporting.
Social
INTS provides no visible workforce, safety, or human-capital metrics here, leaving social oversight less demonstrable than peers with fuller disclosure.
Zero stock-based compensation to revenue suggests limited reliance on equity incentives, but peers often pair incentives with broader retention and culture metrics.
The lack of disclosed social KPIs makes it difficult to evidence stronger labor, diversity, or training practices relative to better-reporting peers.
Overall social positioning appears middling because disclosure gaps, rather than identified controversies, are the main factor versus peers.
Governance
The very low debt-to-equity ratio indicates conservative capital structure, which can support governance discipline relative to more leveraged peers.
Net debt to EBITDA of 1.11x suggests manageable leverage, but peers with stronger governance often pair this with clearer capital-allocation disclosure.
Zero stock-based compensation to revenue may limit dilution concerns, yet peers usually provide more explicit executive-incentive transparency and oversight detail.
Governance appears slightly better than average on balance-sheet discipline, but limited disclosure prevents a stronger relative ESG assessment.
Overall Score
INTS ranks as a moderate ESG performer versus peers because conservative leverage supports governance, but sparse environmental and social disclosure limits stronger positioning.
Score Driver: Limited ESG Disclosure Across Environmental And Social Dimensions
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on Intensity Therapeutics, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
